0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Serum Albumin Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-26L8907
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Serum Albumin Market Outlook 2022
BUY CHAPTERS

Global Recombinant Human Serum Albumin Market Research Report 2024

Code: QYRE-Auto-26L8907
Report
January 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Human Serum Albumin Market Size

The global Recombinant Human Serum Albumin market was valued at US$ 75 million in 2023 and is anticipated to reach US$ 121.1 million by 2030, witnessing a CAGR of 7.2% during the forecast period 2024-2030.

Recombinant Human Serum Albumin Market

Recombinant Human Serum Albumin Market

Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins.
Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Serum Albumin.

Report Scope

The Recombinant Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Recombinant Human Serum Albumin Market Report

Report Metric Details
Report Name Recombinant Human Serum Albumin Market
Accounted market size in 2023 US$ 75 million
Forecasted market size in 2030 US$ 121.1 million
CAGR 7.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • OsrHSA
  • ScrHSA
Segment by Application
  • Cell Culture Media
  • Medical Supplements
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Human Serum Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Human Serum Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Human Serum Albumin Market growing?

Ans: The Recombinant Human Serum Albumin Market witnessing a CAGR of 7.2% during the forecast period 2024-2030.

What is the Recombinant Human Serum Albumin Market size in 2030?

Ans: The Recombinant Human Serum Albumin Market size in 2030 will be US$ 121.1 million.

What is the market share of major companies in Recombinant Human Serum Albumin Market?

Ans: The top three manufacturers account for about 88% of the global share.

What is the Recombinant Human Serum Albumin Market production share by region?

Ans: North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively.

What is the Recombinant Human Serum Albumin Market share by region?

Ans: North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively.

What is the Recombinant Human Serum Albumin Market share by type?

Ans: In terms of product type, ScrHSA is the largest segment, holding about 91% share.

Who are the main players in the Recombinant Human Serum Albumin Market report?

Ans: The main players in the Recombinant Human Serum Albumin Market are Albumedix, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia

What are the Application segmentation covered in the Recombinant Human Serum Albumin Market report?

Ans: The Applications covered in the Recombinant Human Serum Albumin Market report are Cell Culture Media, Medical Supplements, Other

What are the Type segmentation covered in the Recombinant Human Serum Albumin Market report?

Ans: The Types covered in the Recombinant Human Serum Albumin Market report are OsrHSA, ScrHSA

1 Recombinant Human Serum Albumin Market Overview
1.1 Product Overview and Scope of Recombinant Human Serum Albumin
1.2 Recombinant Human Serum Albumin Segment by Type
1.2.1 Global Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2030)
1.2.2 OsrHSA
1.2.3 ScrHSA
1.3 Recombinant Human Serum Albumin Segment by Application
1.3.1 Global Recombinant Human Serum Albumin Market Value by Application: (2024-2030)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Other
1.4 Global Recombinant Human Serum Albumin Market Size Estimates and Forecasts
1.4.1 Global Recombinant Human Serum Albumin Revenue 2019-2030
1.4.2 Global Recombinant Human Serum Albumin Sales 2019-2030
1.4.3 Global Recombinant Human Serum Albumin Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Recombinant Human Serum Albumin Market Competition by Manufacturers
2.1 Global Recombinant Human Serum Albumin Sales Market Share by Manufacturers (2019-2024)
2.2 Global Recombinant Human Serum Albumin Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Recombinant Human Serum Albumin Average Price by Manufacturers (2019-2024)
2.4 Global Recombinant Human Serum Albumin Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Human Serum Albumin, Product Type & Application
2.7 Recombinant Human Serum Albumin Market Competitive Situation and Trends
2.7.1 Recombinant Human Serum Albumin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Recombinant Human Serum Albumin Players Market Share by Revenue
2.7.3 Global Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Recombinant Human Serum Albumin Retrospective Market Scenario by Region
3.1 Global Recombinant Human Serum Albumin Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Recombinant Human Serum Albumin Global Recombinant Human Serum Albumin Sales by Region: 2019-2030
3.2.1 Global Recombinant Human Serum Albumin Sales by Region: 2019-2024
3.2.2 Global Recombinant Human Serum Albumin Sales by Region: 2025-2030
3.3 Global Recombinant Human Serum Albumin Global Recombinant Human Serum Albumin Revenue by Region: 2019-2030
3.3.1 Global Recombinant Human Serum Albumin Revenue by Region: 2019-2024
3.3.2 Global Recombinant Human Serum Albumin Revenue by Region: 2025-2030
3.4 North America Recombinant Human Serum Albumin Market Facts & Figures by Country
3.4.1 North America Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.4.3 North America Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Human Serum Albumin Market Facts & Figures by Country
3.5.1 Europe Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.5.3 Europe Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Human Serum Albumin Market Facts & Figures by Country
3.6.1 Asia Pacific Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.6.3 Asia Pacific Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Recombinant Human Serum Albumin Market Facts & Figures by Country
3.7.1 Latin America Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.7.3 Latin America Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Human Serum Albumin Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Human Serum Albumin Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Recombinant Human Serum Albumin Sales by Country (2019-2030)
3.8.3 Middle East and Africa Recombinant Human Serum Albumin Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Human Serum Albumin Sales by Type (2019-2030)
4.1.1 Global Recombinant Human Serum Albumin Sales by Type (2019-2024)
4.1.2 Global Recombinant Human Serum Albumin Sales by Type (2025-2030)
4.1.3 Global Recombinant Human Serum Albumin Sales Market Share by Type (2019-2030)
4.2 Global Recombinant Human Serum Albumin Revenue by Type (2019-2030)
4.2.1 Global Recombinant Human Serum Albumin Revenue by Type (2019-2024)
4.2.2 Global Recombinant Human Serum Albumin Revenue by Type (2025-2030)
4.2.3 Global Recombinant Human Serum Albumin Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant Human Serum Albumin Price by Type (2019-2030)
5 Segment by Application
5.1 Global Recombinant Human Serum Albumin Sales by Application (2019-2030)
5.1.1 Global Recombinant Human Serum Albumin Sales by Application (2019-2024)
5.1.2 Global Recombinant Human Serum Albumin Sales by Application (2025-2030)
5.1.3 Global Recombinant Human Serum Albumin Sales Market Share by Application (2019-2030)
5.2 Global Recombinant Human Serum Albumin Revenue by Application (2019-2030)
5.2.1 Global Recombinant Human Serum Albumin Revenue by Application (2019-2024)
5.2.2 Global Recombinant Human Serum Albumin Revenue by Application (2025-2030)
5.2.3 Global Recombinant Human Serum Albumin Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant Human Serum Albumin Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Albumedix
6.1.1 Albumedix Corporation Information
6.1.2 Albumedix Description and Business Overview
6.1.3 Albumedix Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Albumedix Recombinant Human Serum Albumin Product Portfolio
6.1.5 Albumedix Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Recombinant Human Serum Albumin Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Ventria (InVitria)
6.3.1 Ventria (InVitria) Corporation Information
6.3.2 Ventria (InVitria) Description and Business Overview
6.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ventria (InVitria) Recombinant Human Serum Albumin Product Portfolio
6.3.5 Ventria (InVitria) Recent Developments/Updates
6.4 NCPC
6.4.1 NCPC Corporation Information
6.4.2 NCPC Description and Business Overview
6.4.3 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.4.4 NCPC Recombinant Human Serum Albumin Product Portfolio
6.4.5 NCPC Recent Developments/Updates
6.5 Oryzogen
6.5.1 Oryzogen Corporation Information
6.5.2 Oryzogen Description and Business Overview
6.5.3 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Oryzogen Recombinant Human Serum Albumin Product Portfolio
6.5.5 Oryzogen Recent Developments/Updates
6.6 HiMedia
6.6.1 HiMedia Corporation Information
6.6.2 HiMedia Description and Business Overview
6.6.3 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2019-2024)
6.6.4 HiMedia Recombinant Human Serum Albumin Product Portfolio
6.6.5 HiMedia Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Human Serum Albumin Industry Chain Analysis
7.2 Recombinant Human Serum Albumin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Human Serum Albumin Production Mode & Process
7.4 Recombinant Human Serum Albumin Sales and Marketing
7.4.1 Recombinant Human Serum Albumin Sales Channels
7.4.2 Recombinant Human Serum Albumin Distributors
7.5 Recombinant Human Serum Albumin Customers
8 Recombinant Human Serum Albumin Market Dynamics
8.1 Recombinant Human Serum Albumin Industry Trends
8.2 Recombinant Human Serum Albumin Market Drivers
8.3 Recombinant Human Serum Albumin Market Challenges
8.4 Recombinant Human Serum Albumin Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Recombinant Human Serum Albumin Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Recombinant Human Serum Albumin Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Recombinant Human Serum Albumin Sales (Kg) of Key Manufacturers (2019-2024)
    Table 5. Global Recombinant Human Serum Albumin Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Recombinant Human Serum Albumin Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Recombinant Human Serum Albumin Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Recombinant Human Serum Albumin Average Price (US$/g) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Recombinant Human Serum Albumin, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Recombinant Human Serum Albumin, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Recombinant Human Serum Albumin, Product Type & Application
    Table 12. Global Key Manufacturers of Recombinant Human Serum Albumin, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Serum Albumin as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Recombinant Human Serum Albumin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Recombinant Human Serum Albumin Sales by Region (2019-2024) & (Kg)
    Table 18. Global Recombinant Human Serum Albumin Sales Market Share by Region (2019-2024)
    Table 19. Global Recombinant Human Serum Albumin Sales by Region (2025-2030) & (Kg)
    Table 20. Global Recombinant Human Serum Albumin Sales Market Share by Region (2025-2030)
    Table 21. Global Recombinant Human Serum Albumin Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Recombinant Human Serum Albumin Revenue Market Share by Region (2019-2024)
    Table 23. Global Recombinant Human Serum Albumin Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Recombinant Human Serum Albumin Revenue Market Share by Region (2025-2030)
    Table 25. North America Recombinant Human Serum Albumin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Recombinant Human Serum Albumin Sales by Country (2019-2024) & (Kg)
    Table 27. North America Recombinant Human Serum Albumin Sales by Country (2025-2030) & (Kg)
    Table 28. North America Recombinant Human Serum Albumin Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Recombinant Human Serum Albumin Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Recombinant Human Serum Albumin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Recombinant Human Serum Albumin Sales by Country (2019-2024) & (Kg)
    Table 32. Europe Recombinant Human Serum Albumin Sales by Country (2025-2030) & (Kg)
    Table 33. Europe Recombinant Human Serum Albumin Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Recombinant Human Serum Albumin Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Recombinant Human Serum Albumin Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Recombinant Human Serum Albumin Sales by Region (2019-2024) & (Kg)
    Table 37. Asia Pacific Recombinant Human Serum Albumin Sales by Region (2025-2030) & (Kg)
    Table 38. Asia Pacific Recombinant Human Serum Albumin Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Recombinant Human Serum Albumin Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Recombinant Human Serum Albumin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Recombinant Human Serum Albumin Sales by Country (2019-2024) & (Kg)
    Table 42. Latin America Recombinant Human Serum Albumin Sales by Country (2025-2030) & (Kg)
    Table 43. Latin America Recombinant Human Serum Albumin Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Recombinant Human Serum Albumin Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Recombinant Human Serum Albumin Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Recombinant Human Serum Albumin Sales by Country (2019-2024) & (Kg)
    Table 47. Middle East & Africa Recombinant Human Serum Albumin Sales by Country (2025-2030) & (Kg)
    Table 48. Middle East & Africa Recombinant Human Serum Albumin Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Recombinant Human Serum Albumin Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Recombinant Human Serum Albumin Sales (Kg) by Type (2019-2024)
    Table 51. Global Recombinant Human Serum Albumin Sales (Kg) by Type (2025-2030)
    Table 52. Global Recombinant Human Serum Albumin Sales Market Share by Type (2019-2024)
    Table 53. Global Recombinant Human Serum Albumin Sales Market Share by Type (2025-2030)
    Table 54. Global Recombinant Human Serum Albumin Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Recombinant Human Serum Albumin Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Recombinant Human Serum Albumin Revenue Market Share by Type (2019-2024)
    Table 57. Global Recombinant Human Serum Albumin Revenue Market Share by Type (2025-2030)
    Table 58. Global Recombinant Human Serum Albumin Price (US$/g) by Type (2019-2024)
    Table 59. Global Recombinant Human Serum Albumin Price (US$/g) by Type (2025-2030)
    Table 60. Global Recombinant Human Serum Albumin Sales (Kg) by Application (2019-2024)
    Table 61. Global Recombinant Human Serum Albumin Sales (Kg) by Application (2025-2030)
    Table 62. Global Recombinant Human Serum Albumin Sales Market Share by Application (2019-2024)
    Table 63. Global Recombinant Human Serum Albumin Sales Market Share by Application (2025-2030)
    Table 64. Global Recombinant Human Serum Albumin Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Recombinant Human Serum Albumin Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Recombinant Human Serum Albumin Revenue Market Share by Application (2019-2024)
    Table 67. Global Recombinant Human Serum Albumin Revenue Market Share by Application (2025-2030)
    Table 68. Global Recombinant Human Serum Albumin Price (US$/g) by Application (2019-2024)
    Table 69. Global Recombinant Human Serum Albumin Price (US$/g) by Application (2025-2030)
    Table 70. Albumedix Corporation Information
    Table 71. Albumedix Description and Business Overview
    Table 72. Albumedix Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
    Table 73. Albumedix Recombinant Human Serum Albumin Product
    Table 74. Albumedix Recent Developments/Updates
    Table 75. Merck Corporation Information
    Table 76. Merck Description and Business Overview
    Table 77. Merck Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
    Table 78. Merck Recombinant Human Serum Albumin Product
    Table 79. Merck Recent Developments/Updates
    Table 80. Ventria (InVitria) Corporation Information
    Table 81. Ventria (InVitria) Description and Business Overview
    Table 82. Ventria (InVitria) Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
    Table 83. Ventria (InVitria) Recombinant Human Serum Albumin Product
    Table 84. Ventria (InVitria) Recent Developments/Updates
    Table 85. NCPC Corporation Information
    Table 86. NCPC Description and Business Overview
    Table 87. NCPC Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
    Table 88. NCPC Recombinant Human Serum Albumin Product
    Table 89. NCPC Recent Developments/Updates
    Table 90. Oryzogen Corporation Information
    Table 91. Oryzogen Description and Business Overview
    Table 92. Oryzogen Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
    Table 93. Oryzogen Recombinant Human Serum Albumin Product
    Table 94. Oryzogen Recent Developments/Updates
    Table 95. HiMedia Corporation Information
    Table 96. HiMedia Description and Business Overview
    Table 97. HiMedia Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2019-2024)
    Table 98. HiMedia Recombinant Human Serum Albumin Product
    Table 99. HiMedia Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Recombinant Human Serum Albumin Distributors List
    Table 103. Recombinant Human Serum Albumin Customers List
    Table 104. Recombinant Human Serum Albumin Market Trends
    Table 105. Recombinant Human Serum Albumin Market Drivers
    Table 106. Recombinant Human Serum Albumin Market Challenges
    Table 107. Recombinant Human Serum Albumin Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Recombinant Human Serum Albumin
    Figure 2. Global Recombinant Human Serum Albumin Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Recombinant Human Serum Albumin Market Share by Type in 2023 & 2030
    Figure 4. OsrHSA Product Picture
    Figure 5. ScrHSA Product Picture
    Figure 6. Global Recombinant Human Serum Albumin Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Recombinant Human Serum Albumin Market Share by Application in 2023 & 2030
    Figure 8. Cell Culture Media
    Figure 9. Medical Supplements
    Figure 10. Other
    Figure 11. Global Recombinant Human Serum Albumin Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Recombinant Human Serum Albumin Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Recombinant Human Serum Albumin Sales (2019-2030) & (Kg)
    Figure 14. Global Recombinant Human Serum Albumin Average Price (US$/g) & (2019-2030)
    Figure 15. Recombinant Human Serum Albumin Report Years Considered
    Figure 16. Recombinant Human Serum Albumin Sales Share by Manufacturers in 2023
    Figure 17. Global Recombinant Human Serum Albumin Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Recombinant Human Serum Albumin Players: Market Share by Revenue in 2023
    Figure 19. Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Recombinant Human Serum Albumin Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Recombinant Human Serum Albumin Sales Market Share by Country (2019-2030)
    Figure 22. North America Recombinant Human Serum Albumin Revenue Market Share by Country (2019-2030)
    Figure 23. United States Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Recombinant Human Serum Albumin Sales Market Share by Country (2019-2030)
    Figure 26. Europe Recombinant Human Serum Albumin Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Recombinant Human Serum Albumin Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Recombinant Human Serum Albumin Revenue Market Share by Region (2019-2030)
    Figure 34. China Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Recombinant Human Serum Albumin Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Recombinant Human Serum Albumin Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Recombinant Human Serum Albumin Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Recombinant Human Serum Albumin Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Recombinant Human Serum Albumin Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Recombinant Human Serum Albumin by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Recombinant Human Serum Albumin by Type (2019-2030)
    Figure 56. Global Recombinant Human Serum Albumin Price (US$/g) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Recombinant Human Serum Albumin by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Recombinant Human Serum Albumin by Application (2019-2030)
    Figure 59. Global Recombinant Human Serum Albumin Price (US$/g) by Application (2019-2030)
    Figure 60. Recombinant Human Serum Albumin Value Chain
    Figure 61. Recombinant Human Serum Albumin Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS